Abstract
Several reports have indicated that platelet-activating factor (PAF) may play a role in the physiopathology of nervous tissue. We previously have demonstrated the presence, in the microsomal fractions of rat brain, of a phosphocholinetransferase which is able to synthesize PAF by thede novo pathway. The presence of dithiothreitol in the medium increases the rate of PAF biosynthesis, whereas it inhibits the synthesis of long-chain alkylacyl- and diacyl-glycerophosphocholines (GPC), including dioctanoyl-GPC. This and other properties, such as pH dependence and thermal stability, indicate that rat brain may have two distinct enzymes for the synthesis of PAF and other choline phospholipids. The affinity of these enzymes for CDPcholine is similar to that reported for other tissues, the Km being 42 μm and 55 μm with alkylacetylglycerol and dioctanoylglycerol as lipid substrates, respectively. The Vmax values were 3.0 and 2.2 nmol/mg prot/min for PAF and dioctanoyl-GPC, respectively. In addition, it was shown that the microsomal fraction of rat brain contains an acetyltransferase which can convert lysoPAF to PAF. Since it has been reported previously that brain tissue possesses phospholipase A2 activity that can hydrolyze alkylacyl-GPC to lysoPAF, we conclude that brain tissue has all enzymic activities for the synthesis of PAF by the “remodeling pathway”. The role of the two routes of PAF biosynthesis in nervous tissue remains to be established.
Similar content being viewed by others
Abbreviations
- DO:
-
dioctanoyl
- DTT:
-
dithiothreitol
- G:
-
glycerol
- GPC:
-
glycero-3-phosphocholine
- PAF:
-
platelet-activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
References
Tokumura, A., Kamiyasu, K., Takauchi, K., and Tsukatani, H. (1987)Biochem. Biophys. Res. Commun. 145, 415–425.
Tokumura, A., Takauchi, K., Asai, T., Kamiyasu, K., Ogawa, T. and Tsukatani, H. (1989)J. Lipid Res. 30, 219–224.
Kumar, R., Harvey, S.A.K., Kester, M., Hanahan, D.J., and Olson, M.S. (1988)Biochim. Biophys. Acta 963, 375–383.
Bussolino, F., Gremo, F., Tetta, C., Pescarmona, G.P., and Camussi, G. (1986)J. Biol. Chem. 261, 16502–16508.
Kornecki, E., and Ehrlich, Y.H. (1988)Science 240, 1792–1794.
Panetta, T., Marcheselli, V.L., Braquet, P., Spinnewyn, B., and Bazan, N.G. (1987)Biochem. Biophys. Res. Commun. 149, 580–587.
Bazan, N.G. (1970)Biochim. Biophys. Acta 149, 580–587.
De Medio, G.E., Goracci, G., Horrocks, L.A., Lazarewicz, J.W., Mazzari, S., Porcellati, G., Strosznajder, J., and Trovarelli, G. (1980)Ital. J. Biochem. 29, 412–432.
Snyder, F. (1987) inNew Horizons in Platelet Activating Factor Research (Winslow, C.M., and Lee, M.L., eds.), pp. 13–25, J. Wiley and Sons, Ltd., London.
Renooij, W., and Snyder, F. (1981)Biochim. Biophys. Acta 663, 545–556.
Wykle, R.L., Malone, B., and Snyder, F. (1980)J. Biol. Chem. 255, 10256–10260.
Francescangeli, E., and Goracci, G. (1989)Biochem. Biophys. Res. Commun. 161, 107–112.
Lee, T-c., Malone, B., and Snyder, F. (1986)J. Biol. Chem. 261, 5373–5377.
Lee, T-c., Malone, B., and Snyder, F. (1988)J. Biol. Chem. 263, 1755–1760.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–275.
Francescangeli, E., Porcellati, S., Horrocks, L.A., and Goracci, G., (1987)J. Liquid Chromat. 10, 2799–2808.
Bligh, E.G., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.
McCaman, R.E., and Cook, K. (1966)J. Biol. Chem. 241, 3390–3394.
Binaglia, L., Goracci, G., Porcellati, G., Roberti, R., and Woelk, H., (1973)J. Neurochem. 21, 1067–1082.
Woodard, D.S., Lee, T-c., and Snyder, F. (1987)J. Biol. Chem. 262, 2520–2527.
Reddy, T.S., and Horrocks, L.A. (1985)Neurochem. Res. 10, 1445–1452.
Lenihan, D.J., and Lee, T-c. (1984)Biochem. Biophys. Res. Commun. 120, 834–839.
Freysz, L., Horrocks, L.A., and Mandel, P. (1980)J. Neurochem. 34, 963–969.
Radominska-Pyrek, A., Strosznajder, J., Dabrowiecki, Z., Goracci, G., Chojnacki, T., and Horrocks, L.A. (1977)J. Lipid Res. 18, 53–58.
Clarke, N.G., and Dawson, R.M.C. (1981)Biochem. J. 195, 301–306.
Albert, D.H., and Snyder, F. (1983)J. Biol. Chem. 258, 97–102.
Woelk, H., Goracci, G., and Porcellati, G. (1974)Hoppe-Seyler's Z. Physiol. Chem. 355, 75–81.
Woelk, H., Peiler-Ichikawa, K., Binaglia, L., Goracci, G., and Porcellati, G. (1974)Hoppe-Seyler's Z. Physiol. Chem. 355, 1535–1542.
Woelk, H., Goracci, G., Gaiti, A., and Porcellati, G. (1973)Hoppe-Seyler's Z. Physiol. Chem. 354, 729–736.
Porcellati, G., Biasion, M., and Arienti, G. (1970)Lipids 5, 725–733.
Bussolino, F., Pescarmona, G.P., Camussi, G., and Gremo, F. (1988)J. Neurochem. 51, 1755–1759.
Bazan, N.G., Birkle, D.L., Tang, W., and Reddy, T.S. (1976)Adv. Neurol. 44, 879–902.
Alonso, F., Garcia Gil, M., Sanchez-Crespo, M., and Mato, J.M. (1982)J. Biol. Chem. 257, 3376–3378.
Ninio, E., Mencia-Huerta, J.M., and Benveniste, J. (1973)Biochim. Biophys. Acta 751, 298–304.
Blank, M.L., Lee, T-c., Fitzgerald, V., and Snyder, F. (1981)J. Biol. Chem. 256, 175–178.
Author information
Authors and Affiliations
About this article
Cite this article
Goracci, G., Francescangeli, E. Properties of PAF-synthesizing phosphocholinetransferase and evidence for lysoPAF acetyltransferase activity in rat brain. Lipids 26, 986–991 (1991). https://doi.org/10.1007/BF02536489
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536489